Last Updated on January 14, 2024 by The Health Master
Long term benefits of Covaxin
New Delhi: Research led by the National Institute of Immunology, along with several other government institutions, has for the first time confirmed Covaxin-induced immune memory, indicating that the C-19 vaccine is capable of ensuring long term protection against severe disease.
The study, funded by the Centre’s department of biotechnology, has shown that T and B cell memory responses generated by Covaxin measures are similar to the memory responses generated by the natural infection.
The finding is significant, especially as various researches have now proven that antibodies – another marker of a vaccine’s efficacy – generated after being vaccinated with Covaxin is significantly lower as compared to Covishield, the other vaccine used in India.
Covaxin is India’s first fully indigenously developed C-19 vaccine, developed by Hyderabad-based Bharat Biotech in collaboration with the ICMR. Recently, it was granted an emergency use listing by the WHO.
The latest report led by NII scientists which determined the magnitude, quality and persistence of cellular and humoral memory responses up to six months after vaccination with Covaxin, says the quantity of vaccine-induced spike and nucleoprotein antibodies is comparable to that following natural infection and the antibodies are detectable up to six months.
The RBD-specific antibodies decline in the range of 3 to 10-fold against SARS-CoV-2 variants in the order of alpha, delta, beta, with no observed impact of gamma and kappa variants.
“We found that the vaccine induces memory B cells, similar to natural infection, which are impacted by virus variants in the same order as antibodies,” noted the researchers.
The findings released in a pre-print for medical research establish that the inactivated vaccine Covaxin induces robust immune memory to SARS-CoV-2 and variants of concern, which persist for at least six months after vaccination.
“This study has implication for future vaccine development, guidance for use of inactivated virus vaccine, and booster immunisation,” it said.
Immune memory up to six months
The findings establish that the inactivated vaccine Covaxin induces robust immune memory to SARS-CoV-2 and variants of concern, which persists for at least six months after vaccination.
Lung cancer management in the era of precision medicine
CDSCO panel rejects Synokem Pharma’s application for oral Antidiabetic Drug
PLI schemes for Pharma and Medical Devices to make India secure
Zydus Cadila gets USFDA nod to market generic Cancer drug in…
Govt transfers AYUSH-64 drug technology to 46 Companies
Eli Lilly files litigation against 20 Indian Pharma Companies
Experts ask Govt to bring list of OTC Drugs
Retired FDA officials are promoting Generic Drugs in innovative ways
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
